CD200-receptor mediated modulation of bone development

Details for Australian Patent Application No. 2009217461 (hide)

Owner Trillium Therapeutics Inc.

Inventors Gorczynski, Reginald M.

Agent FB Rice

Pub. Number AU-A-2009217461

Parent 2003233721

Filing date 23 September 2009

Wipo publication date 15 October 2009

International Classifications

A61K 31/00 (2006.01)

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

8 October 2009 Complete Application Filed

15 October 2009 Application Open to Public Inspection

  Published as AU-A-2009217461

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217462-Wavily deformable stent and method for producing the same

2009217460-Gene differentially expressed in breast and bladder cancer and encoded poly- peptides